Indrayani Biotech Ltd — Board Meeting, 14-08-2025: Board Meeting

Indrayani Biotech Limited has announced a board meeting where it approved the financial results for the quarter. For the latest quarter, standalone revenue stood at ₹6.69 Cr with a net profit of ₹0.13 Cr, and EPS at ₹0.03. Consolidated revenue was ₹29.10 Cr, with a net profit of ₹0.16 Cr, and EPS also at ₹0.03. The statutory auditors have provided an unmodified opinion on these unaudited results, offering transparency into the company's recent financial performance for shareholders.